LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $420,800,369 | -2.7% | 6,264,707 | 0.0% | 8.28% | +1.5% |
| Q2 2023 | $432,452,724 | +268.1% | 6,264,707 | +157.1% | 8.16% | +207.1% |
| Q1 2023 | $117,474,673 | -3.4% | 2,436,223 | 0.0% | 2.66% | +7.8% |
| Q4 2022 | $121,616,252 | +27.5% | 2,436,223 | +4.2% | 2.47% | +21.2% |
| Q3 2022 | $95,415,000 | +137.8% | 2,338,610 | +139.2% | 2.04% | +216.1% |
| Q2 2021 | $40,126,000 | -40.8% | 977,503 | -59.4% | 0.64% | -32.1% |
| Q4 2020 | $67,818,000 | -8.8% | 2,408,292 | 0.0% | 0.95% | -30.3% |
| Q3 2020 | $74,344,000 | -29.6% | 2,408,292 | -3.0% | 1.36% | -33.9% |
| Q2 2020 | $105,631,000 | – | 2,481,942 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |